Clenbuterol: Research, Dosing, and Where to Buy in 2026
A research-first profile for Clenbuterol (Clen, Clenbuterol hydrochloride, Spiropent, Ventipulmin (veterinary)), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Clenbuterol is a long-acting beta-2 adrenergic agonist. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for Clenbuterol, each linked to its source.
- Also indexed as Clen, Clenbuterol hydrochloride, Spiropent, Ventipulmin (veterinary).
- Clenbuterol is a long-acting beta-2 adrenergic agonist. It is approved in a number of countries as a bronchodilator for asthma and other reversible airway conditions, and in the United States it is approved only for...
- Mechanism notes include Clenbuterol stimulates beta-2 adrenoceptors, activating adenylate cyclase and raising intracellular cyclic AMP. In the airways this relaxes bronchial smooth muscle;...
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
- Evidence level in this entry is marked as Clinical / pharmacological.
What is Clenbuterol?
Clenbuterol is a long-acting beta-2 adrenergic agonist. It is approved in a number of countries as a bronchodilator for asthma and other reversible airway conditions, and in the United States it is approved only for veterinary use (in horses, as Ventipulmin); it is not approved for human use in the US. It is not a steroid, although it is often grouped with performance compounds because of its off-label use for fat loss.
How does Clenbuterol work?
Clenbuterol stimulates beta-2 adrenoceptors, activating adenylate cyclase and raising intracellular cyclic AMP. In the airways this relaxes bronchial smooth muscle; systemically it increases thermogenesis and lipolysis and has mild anabolic / anti-catabolic effects in skeletal muscle in animal models. Its long half-life means effects and side effects persist for many hours.
Mechanism note
These mechanisms are presented as research observations and hypotheses from the indexed data, not as confirmation of clinical effect in humans.
What is Clenbuterol researched for?
Where approved for people, clenbuterol is prescribed to relax airway smooth muscle and relieve bronchospasm. Off-label and illicitly it is used as a thermogenic 'cutting' agent, because beta-2 stimulation raises metabolic rate and promotes fat oxidation while sparing some lean mass. The Peptide Wiki documents this for education only and does not recommend non-prescribed use.
Clenbuterol Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Vigorous Steve / Steve | Prevent Insulin Resistance On High-Dose GH, Mirabegron Vs. Clen Vs.... | 01:25:22 | Vigorous Steve reported using 20 mcg clenbuterol as part of a fat-burning protocol, describing it as a tolerable dose. Clenbuterol is not FDA-approved for human use in the United States. | anecdotal |
Where to Buy Clenbuterol in 2026
No tracked vendor recommendations for Clenbuterol yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Clenbuterol. Each line links to the original source.
- "Compared to placebo, clenbuterol induced a 0.91 kg lean mass gain (95% confidence interval = 0.02-1.81, P < 0.05) but had no effect on fat mass." · Hostrup M et al, 2025 PubMed
- "Clenbuterol reduced maximal oxygen uptake by 7% (P < 0.001) and exercise capacity by 4% (P < 0.001) but had no effects on sprint power output, left ventricular mass, intravascular blood volume or haemoglobin mass." · Hostrup M et al, 2025 PubMed
Research and Studies
8 PubMed-indexed papers reference Clenbuterol. Top 8 shown.
Legal Status
Clenbuterol is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
What is Clenbuterol?
Clenbuterol is a long-acting beta-2 adrenergic agonist. It is approved in a number of countries as a bronchodilator for asthma and other reversible airway conditions, and in the United States it is approved only for veterinary use (in horses, as Ventipulmin); it is not approved for human use in the US. It is not a steroid, although it is often grouped with performance compounds because of its off-label use for fat loss.
Is Clenbuterol FDA-approved?
Clenbuterol is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for Clenbuterol?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on Clenbuterol?
8 PubMed-indexed paper(s) reference Clenbuterol in our current research feed. See the Research and Studies section above for citations.